Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Under the agreement, Porton Advanced will provide services to accelerate the development, production and registration of breakthrough cell therapies currently being developed by Sinorda Biomedicine
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
The expansion makes Exothera one of the largest viral vector facilities in Europe
Subscribe To Our Newsletter & Stay Updated